Lawsuit is part of a nationwide strategy by Novo Nordisk to protect its trademark and profits from its blockbuster GLP-1 drugs.

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to set them up with Wegovy, Zepbound and other weight-loss drugs.

With weight-loss injectables now being sold at Costco and other major retailers, drugs like Ozempic are becoming more mainstream and accessible to the public. However, if you’re new to the world of GLP-1 medications or are thinking about switching prescriptions due to side effects,

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and Saxenda. Here's what to know.

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in recent years.

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the average weight loss seen with semaglutide.

Weight loss drugs have gone viral. But despite their availability, most people who could benefit from treatments can't access them.

Daily” pill is the latest product to capitalize on the weight loss drug craze. By Dani Blum There’s a long list of products that companies and influencers claim can deliver quick and dramatic weight loss,

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal body weight,” with his cholesterol below 200 for the first time in 20 years.

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other GLP-1s, such as semaglutide, the active ingredient in Ozempic. A rapid drop in weight can result in a loss of bone density,